SEC Comment Letter for CollPlant Biotechnologies Ltd (CLGN) (CIK 0001631487) (CLGN) — Sep 7, 2018
CollPlant Biotechnologies Ltd (CLGN) (CIK 0001631487)
Date: Sept. 7, 2018 · CIK: 0001631487 · Accession: 0000000000-18-027879
AI Filing Summary & Sentiment
Show Raw Text
September 6, 2018
Yehiel Tal
Chief Executive Officer
CollPlant Holdings Ltd.
3 Sapir Street, Weizmann Science Park
Ness-Ziona 74140, Israel
Re:CollPlant Holdings Ltd.
Draft Registration Statement on Form F-1
Submitted August 30, 2018
CIK No. 0001631487
Dear Mr. Tal:
This is to advise you that we do not intend to review your registration statement.
We request that you publicly file your registration statement no later than 48 hours prior
to the requested effective date and time. Please refer to Rules 460 and 461 regarding requests for
acceleration. We remind you that the company and its management are responsible for the
accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or
absence of action by the staff.
Please contact Tim Buchmiller at (202) 551-3635 with any questions.
Sincerely,
Division of Corporation Finance
Office of Electronics and Machinery
cc: Gary Emmanuel, Esq.